Notes / Company

Trident Lifeline Ltd.

TLL BSE 543616 ISIN INE0MKA01014 Pharmaceuticals

Fundamentals

Market cap: ₹292 cr
P/E: 15.35×
ROE: 18.23%
Debt / equity: 0.84
52-week range: 229.95 — 328.00

The timeline — 1 note on Trident Lifeline Ltd.

June 2026

13 Jun 26 · 4:01 PM IST Lead

Lead · Micro cap

Trident Lifeline gets board nod for main board migration

The nano-cap pharma company plans to shift from BSE SME to main boards of BSE and NSE. New independent directors bring financial and pharma expertise.

Verify on exchange BSE filings for TLL NSE filings for TLL